BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zapata RC, Rosenthal SB, Fisch K, Dao K, Jain M, Osborn O. Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain. Sci Rep 2020;10:18581. [PMID: 33122657 DOI: 10.1038/s41598-020-75624-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Guan X, Xu J, Xiu M, Li X, Liu H, Wu F. Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study. CNS Neurosci Ther 2022. [PMID: 35769008 DOI: 10.1111/cns.13895] [Reference Citation Analysis]
2 Al-Tobi Z, Al Suleimani Y, Al-Rasadi K, Al-Shabibi S, Al Mahrizi A, Al-Maqbali J, Al-Waili K, Al-Adawi S, Al-Zakwani I. Metabolic Side Effects of Olanzapine in Patients With Psychotic Disorders in Oman: A Retrospective Cohort Study. Angiology 2022;:33197211072340. [PMID: 35113727 DOI: 10.1177/00033197211072340] [Reference Citation Analysis]
3 Liu JH, Chen N, Guo YH, Guan XN, Wang J, Wang D, Xiu MH. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia. J Psychiatr Res 2021;140:409-15. [PMID: 34144444 DOI: 10.1016/j.jpsychires.2021.06.001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]